The global contraceptive devices market size attained a value of about USD 10.86 billion in 2022. The market is anticipated to grow further at a CAGR of 6.55% during the forecast period of 2023-2031 to attain a value of USD 19.23 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rise in challenges of obtaining abortions, high costs of child-rearing, busy lifestyles, active sexual lives, and the overall preference of avoiding unintended pregnancies, is driving the growth for the contraceptive devices market. The growing awareness regarding the existing alternatives for preventing unwanted pregnancies, especially among women, is also boosting the demand for contraceptive devices. The other key aspects propelling the market growth of contraceptive devices are the increasing healthcare expenditure, coupled with the rising inclination of consumers to prevent unexpected pregnancies.
Moreover, governments of both developed and developing countries are increasingly focusing on population management by spreading awareness and encouraging people to use contraceptive devices. Hence, they are initiating several campaigns and launching various policies/plans/programmes like ‘Mission Parivar Vikas’ in India, which are supporting the growth of the contraceptive devices market. The increasing accessibility to contraceptive devices among all socioeconomic classes, especially in low-income countries, is expected to fuel the market growth in the forecast period.
Contraceptive devices are different birth control tools used to prevent pregnancies, typically by implementing a mechanical barrier to conceptions. These devices act as a physical wall to prevent the sperm from entering the uterus, thereby preventing insemination. They can have short-term or long-term effectiveness, and range from one-time use items to devices that can be used multiple times.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major device types of contraceptive devices are:
The market can be broadly categorised, on the basis of end users, into:
Based on distribution channel, the market is categorised into:
The EMR report looks into the regional markets of contraceptive devices like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rapid urbanisation, increasing disposable income, and changing lifestyles, are some of the major aspects bolstering the market for contraceptive devices across North America. The growing healthcare system and rise in the adoption rate of contraceptive devices in the United States and Canada are supporting the growth of the contraceptive devices market in North America.
Meanwhile, the Asia Pacific region is expected to register a significant market share of contraceptive devices on account of the introduction of favourable initiatives by governments to boost the awareness regarding the importance of contraceptive devices and its effective usage during the forecast period.
The report presents a detailed analysis of the following key players in the global contraceptive devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product Type||
|Breakup by Technology||
|Breakup by Distribution Channel||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Contraceptive Devices Market Overview
3.1 Global Contraceptive Devices Market Historical Value (2016-2022)
3.2 Global Contraceptive Devices Market Forecast Value (2023-2031)
4 Global Contraceptive Devices Market Landscape
4.1 Global Contraceptive Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Contraceptive Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Distribution Channel
5 Global Contraceptive Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Contraceptive Devices Market Segmentation
6.1 Global Contraceptive Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Male Contraceptive Devices
6.1.3 Female Contraceptive Devices
126.96.36.199 Female Condoms
188.8.131.52 Contraceptive Sponges
184.108.40.206 Contraceptive Vaginal Rings
220.127.116.11 Intrauterine Devices
18.104.22.168 Sub-dermal Contraceptive Implants
22.214.171.124 Non-Surgical Permanent Contraceptive Devices
6.2 Global Contraceptive Devices Market by Technology
6.2.1 Market Overview
6.2.2 Hormonal Contraceptives
6.2.3 Barrier Contraceptives
6.3 Global Contraceptive Devices Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Channel
6.3.5 Public Channel
6.4 Global Contraceptive Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Contraceptive Devices Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Contraceptive Devices Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Contraceptive Devices Market
9.1 Market Share by Country
10 Latin America Contraceptive Devices Market
10.1 Market Share by Country
11 Middle East and Africa Contraceptive Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Bayer AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Pfizer Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Janssen Global Services, LLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Teva Pharmaceutical Industries Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Merck Sharp & Dohme Corp.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Mylan N.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Reckitt Benckiser Group plc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Veru Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Medisafe Distribution Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 CooperSurgical, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Mayer Laboratories, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Allergan plc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14 Agile Therapeutics
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.15 HLL Lifecare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.16 ANSELL LTD
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.17 Mankind Pharma
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.18 TTK HealthCare
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.19 Boehringer Ingelheim International GmbH.
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.20 V-Care Pharma Pvt. Ltd.
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.21 VARDHAMAN LIFECARE PVT LTD
17.21.1 Financial Analysis
17.21.2 Product Portfolio
17.21.3 Demographic Reach and Achievements
17.21.4 Mergers and Acquisitions
17.22 Cipla Inc.
17.22.1 Financial Analysis
17.22.2 Product Portfolio
17.22.3 Demographic Reach and Achievements
17.22.4 Mergers and Acquisitions
18 Global Contraceptive Devices Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The global contraceptive devices market is assessed to grow at a CAGR of 6.10% between 2023 and 2031.
The major market drivers are the rising number of unwanted pregnancies, changing lifestyles, and government policies encouraging prevention of unwanted pregnancies.
The key market trends guiding the growth of the market include the increasing disposable incomes, the growing adoption of contraceptive devices, and the surging focus on population management.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The different device types of contraceptive devices include vaginal rings, diaphragms, condoms, cervical caps, sponges, and intra uterine device (IUDs), among others.
The significant end users of contraceptive devices in the market are male and female.
The major distribution channels of contraceptive devices include retail pharmacy, hospital pharmacy, online pharmacy, public channel and NGO, and clinics, among others.
The major players in the market are Janssen Pharmaceutical Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., and Reckitt Benckiser Group PLC, among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.